Injectable Liquid Crystal Formation System for Reshaping Tumor Immunosuppressive Microenvironment to Boost Antitumor Immunity: Postoperative Chemoimmunotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Injectable Liquid Crystal Formation System for Reshaping Tumor Immunosuppressive Microenvironment to Boost Antitumor Immunity: Postoperative Chemoimmunotherapy
Authors
Keywords
-
Journal
Small
Volume 16, Issue 50, Pages 2004905
Publisher
Wiley
Online
2020-11-19
DOI
10.1002/smll.202004905
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses
- (2020) Yu Chao et al. Science Advances
- Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1−CD8+ Tumor-Infiltrating T Cells
- (2019) Sema Kurtulus et al. IMMUNITY
- Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade
- (2019) Brian C. Miller et al. NATURE IMMUNOLOGY
- Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy
- (2019) Hathaichanok Phuengkham et al. ADVANCED MATERIALS
- Surgical Tumor-Derived Personalized Photothermal Vaccine Formulation for Cancer Immunotherapy
- (2019) Xinyu Ye et al. ACS Nano
- In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy
- (2019) Weijing Yang et al. ACS Nano
- Clonal replacement of tumor-specific T cells following PD-1 blockade
- (2019) Kathryn E. Yost et al. NATURE MEDICINE
- Adverse Events Following Cancer Immunotherapy: Obstacles and Opportunities
- (2019) Kristen E. Pauken et al. TRENDS IN IMMUNOLOGY
- Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
- (2019) Xiaopin Duan et al. Nature Communications
- Intracellularly Generated Immunological Gold Nanoparticles for Combinatorial Photothermal Therapy and Immunotherapy against Tumor
- (2019) Dan Zhang et al. NANO LETTERS
- PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity
- (2019) Jianshu Wei et al. Journal for ImmunoTherapy of Cancer
- Lyophilizable and Multifaceted Toll-like Receptor 7/8 Agonist-Loaded Nanoemulsion for the Reprogramming of Tumor Microenvironments and Enhanced Cancer Immunotherapy
- (2019) Sun-Young Kim et al. ACS Nano
- Injectable Hexapeptide Hydrogel for Localized Chemotherapy Prevents Breast Cancer Recurrence
- (2018) Yingqiu Qi et al. ACS Applied Materials & Interfaces
- Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel
- (2018) Honglin Jin et al. ACS Nano
- Implantable Synthetic Immune Niche for Spatiotemporal Modulation of Tumor-Derived Immunosuppression and Systemic Antitumor Immunity: Postoperative Immunotherapy
- (2018) Hathaichanok Phuengkham et al. ADVANCED MATERIALS
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
- (2018) Chao Wang et al. Science Translational Medicine
- Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy
- (2018) Kaiyuan Ni et al. Nature Communications
- Factors Influencing the Differentiation of Human Monocytic Myeloid-Derived Suppressor Cells Into Inflammatory Macrophages
- (2018) Defne Bayik et al. Frontiers in Immunology
- TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
- (2018) Christopher B. Rodell et al. Nature Biomedical Engineering
- Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
- (2018) Jianqin Lu et al. ACS Nano
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
- (2018) Moshe Sade-Feldman et al. CELL
- In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
- (2018) Qian Chen et al. Nature Nanotechnology
- Tumor Microenvironment Responsive Nanogel for the Combinatorial Antitumor Effect of Chemotherapy and Immunotherapy
- (2017) Qingle Song et al. NANO LETTERS
- Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency
- (2017) Miao Kong et al. Theranostics
- Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade
- (2016) Haidong Tang et al. CANCER CELL
- Chemotherapy and immunotherapy: mapping the road ahead
- (2016) Alistair M Cook et al. CURRENT OPINION IN IMMUNOLOGY
- Immune suppressive mechanisms in the tumor microenvironment
- (2016) David H Munn et al. CURRENT OPINION IN IMMUNOLOGY
- A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model
- (2016) Beth C. Holbrook et al. JOURNAL OF IMMUNOLOGY
- Application potential of toll-like receptors in cancer immunotherapy
- (2016) Ming Shi et al. MEDICINE
- Metastasis as an evolutionary process
- (2016) S. Turajlic et al. SCIENCE
- Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM
- (2016) D. Mathios et al. Science Translational Medicine
- An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
- (2016) Yichao Chen et al. Nature Communications
- Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy
- (2016) Chunbai He et al. Nature Communications
- Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
- (2016) Qian Chen et al. Nature Communications
- In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
- (2015) Geoffrey M Lynn et al. NATURE BIOTECHNOLOGY
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK
- (2015) Idit Sagiv-Barfi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence
- (2014) J. Ye et al. EMBO Molecular Medicine
- A new injectable liquid crystal system for one month delivery of leuprolide
- (2014) Min-Hyo Ki et al. JOURNAL OF CONTROLLED RELEASE
- Adjuvant immunotherapy for non-small cell lung cancer
- (2012) Zachary C.G. Tucker et al. CANCER TREATMENT REVIEWS
- Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery
- (2012) J. Predina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery
- (2011) Zhiping Zhang et al. BIOMATERIALS
- Self-Assembled Multicompartment Liquid Crystalline Lipid Carriers for Protein, Peptide, and Nucleic Acid Drug Delivery
- (2010) Angelina Angelova et al. ACCOUNTS OF CHEMICAL RESEARCH
- Lyotropic liquid crystal systems in drug delivery
- (2010) Chenyu Guo et al. DRUG DISCOVERY TODAY
- Adaptive immunity
- (2010) Francisco A. Bonilla et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Surgery induced immunosuppression
- (2010) Brian V. Hogan et al. SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now